Kidney diseases encompass a complex spectrum – from prevalent chronic kidney disease and end-stage renal disease requiring transplantation, to distinctive immunological and glomerular conditions including primary membranous nephropathy, immunoglobulin A nephropathy, atypical haemolytic uraemic syndrome, focal segmental glomerulosclerosis, and complement 3 glomerulopathy. Each presents unique diagnostic, management, and treatment optimisation challenges. With therapeutic innovation accelerating across glomerular and systemic renal diseases, robust real-world evidence is vital for understanding disease trajectories, guiding clinical strategies, supporting reimbursement decisions, and building stakeholder confidence in treatment efficacy.
Adelphi Real World’s Nephrology Disease Specific Programmes (DSPs) are purpose-built to deliver this evidence.
Our Nephrology DSPs engage specialist nephrologists and patients to generate intelligence grounded in authentic clinical practice:
Assessment & Disease Staging
Understand how specialists diagnose, classify, and monitor disease – capturing diagnostic approaches, glomerular assessment methodologies, kidney function monitoring, and disease severity evaluation in routine clinical settings.
Treatment Selection & Renoprotective Strategies
Benchmark real-world therapy patterns: how nephrologists select and sequence treatments – from blood pressure management and immunosuppression through advanced targeted therapies – across the disease spectrum.
Kidney Outcomes & Disease Progression
Track real-world effectiveness: kidney function preservation, proteinuria reduction, disease stabilisation, preventing progression to end-stage renal disease prevention, and transplant outcomes across diverse patient populations and healthcare systems.
Patient Burden & Quality of Life
Explore the patient perspective: symptom burden, treatment tolerability, dialysis and transplant impacts, cardiovascular complications, adherence challenges, and quality-of-life consequences.
Unmet Treatment Needs & Innovation Gaps
Identify areas where current management is inadequate, disease-modifying therapy opportunities, and the specific outcomes that matter most to patients, their caregivers, and nephrologists.
Nephrology Disease Specific Programmes (DSPs) Portfolio
Click on the hexagons to expand.
Why Choose Adelphi For Nephrology Real-World Evidence?
Authentic Nephrologist Networks
Access to practising nephrologists, renal centres, and transplant units across diverse healthcare settings globally.
Glomerular and Rare Disease Research Proficiency
Proven and dedicated capability in complex and rare immunological and glomerular conditions requiring specialist diagnostic and therapeutic knowledge.
Patient-Centred Intelligence
Evidence capturing the lived experience of real-world patients living with kidney diseases and their real-world treatment burden.
Rigorous Methodology
Robust quantitative benchmarking combined with qualitative clinical insight specific to nephrology practice.
Strategic Intelligence
Evidence supporting clinical development, market access, and healthcare stakeholder engagement.
Current Countries Nephrology DSPs Cover
Our Collaborative Network
We partner with pharmaceutical innovators, nephrology centres and transplant units, patient advocacy organisations, and healthcare commissioners to advance nephrology research and improve outcomes for patients worldwide.
Let’s Connect
-
Schedule a Discussion: Meet with our real-world evidence experts in nephrology to explore how our solutions can support your nephrology evidence needs.
-
Learn More: Interested in our nephrologist networks, global coverage, glomerular disease expertise, or research methodologies? Contact us for more comprehensive information.
Your strategy in nephrology – from high-prevalence CKD to rare glomerular conditions – requires research partners with genuine nephrology expertise and authentic access to specialist practitioners. Adelphi Real World brings exactly that, combined with rigorous methodologies and patient- insights. Let’s partner to generate evidence that drives innovation and improves outcomes for patients living with kidney diseases.
Contact us today using the form below.
Conferences Attending
Observational Research